Korkolopoulou P, Oates J, Crocker J, Edwards C
Department of Histopathology, East Birmingham Hospital.
J Clin Pathol. 1993 Dec;46(12):1093-6. doi: 10.1136/jcp.46.12.1093.
To investigate the immunohistochemical expression of p53 protein in small cell lung carcinoma (SCLC), comparing it with that in non-small cell carcinoma (NSCLC); and to evaluate the correlation between p53 and proliferating cell nuclear antigen (PCNA) expression as well as between p53 and PCNA expression and survival.
Paraffin wax embedded tissues from 61 cases of primary lung carcinoma were stained for p53 protein and PCNA using the monoclonal antibodies 1801 and PC-10, respectively, in a standard avidin-biotin immunoperoxidase method.
Of the 61 lung carcinomas 35 (57%) were positive for p53 (range 1% to 90%). Ninety percent of the non-oat SCLC contained positive cells and the labelling index (LI) was significantly higher than that of the oat SCLC (p < 0.001). SLCC also displayed a higher p53 LI than NSCLC (p < 0.01); no difference was found between squamous carcinoma, adenocarcinoma, and oat cell carcinoma. A p53 LI of greater than 1% tended to be associated with nodal metastases (p < 0.05), and p53 expression in node positive tumours as well as in oat cell carcinomas was indicative of poorer survival (p < 0.01 and p < 0.1, respectively). A p53 Li of greater than 60% was a negative prognostic factor in non-oat SCLC (p < 0.05). PCNA LI was highest in non-oat SCLC and lowest in NSCLC; oat cell carcinomas had a mean LI intermediate between NSCLC and non-oat SCLC (NSCLC v oat cell carcinoma p < 0.05 and oat cell v non-oat cell carcinomas p < 0.01). A PCNA LI was not correlated with nodal metastases or survival, but there was a significant positive correlation between PCNA LI and p53 LI (rs = 0.484, p < 0.001).
p53 and PCNA expression differ substantially among the various types of lung carcinomas. Substantial differences were also found between oat and non-oat types of SCLC, indicating that SCLC is heterogeneous as far as proliferation rate and altered p53 expression is concerned. p53 seems to be of some prognostic value. The relation between PCNA and p53 expression indicates that the PCNA gene is slightly upregulated by p53.
研究p53蛋白在小细胞肺癌(SCLC)中的免疫组化表达,并与非小细胞肺癌(NSCLC)进行比较;评估p53与增殖细胞核抗原(PCNA)表达之间的相关性,以及p53和PCNA表达与生存率之间的相关性。
采用标准抗生物素蛋白-生物素免疫过氧化物酶法,分别用单克隆抗体1801和PC-10对61例原发性肺癌石蜡包埋组织进行p53蛋白和PCNA染色。
61例肺癌中,35例(57%)p53呈阳性(范围为1%至90%)。90%的非燕麦型SCLC含有阳性细胞,标记指数(LI)显著高于燕麦型SCLC(p<0.001)。SCLC的p53 LI也高于NSCLC(p<0.01);鳞状细胞癌、腺癌和燕麦细胞癌之间未发现差异。p53 LI大于1%往往与淋巴结转移相关(p<0.05),淋巴结阳性肿瘤以及燕麦细胞癌中的p53表达提示生存率较差(分别为p<0.01和p<0.1)。p53 LI大于60%是非燕麦型SCLC的不良预后因素(p<0.05)。PCNA LI在非燕麦型SCLC中最高,在NSCLC中最低;燕麦细胞癌的平均LI介于NSCLC和非燕麦型SCLC之间(NSCLC与燕麦细胞癌比较,p<0.05;燕麦细胞癌与非燕麦细胞癌比较,p<0.01)。PCNA LI与淋巴结转移或生存率无关,但PCNA LI与p53 LI之间存在显著正相关(rs=0.484,p<0.001)。
p53和PCNA表达在不同类型肺癌中存在显著差异。燕麦型和非燕麦型SCLC之间也存在显著差异,表明就增殖率和p53表达改变而言,SCLC具有异质性。p53似乎具有一定的预后价值。PCNA与p53表达之间的关系表明PCNA基因受p53轻度上调。